Our analyses of data from public databases preliminarily suggest that high expression of NeuroD1 is associated with a highly differentiated phenotype in pancreatic cancer and that NeuroD1 may function as a protective factor in pancreatic cancer. Here, NEUROD1 is linked to pancreatic neoplasm.